Garodia Chemicals Ltd

Dematerialisation status and depository actions

• Securities received for dematerialisation were confirmed (accepted/rejected) to the depositories.
• Securities in the certificates have been listed on the stock exchanges.
• Certificates for dematerialisation were mutilated and cancelled; depository name substituted as registered owner.

Garodia Chemicals Limited: Trading window closed from October 01, 2026 till 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ended September 30, 2026 for all Designated Persons and their Immediate Relatives.

AGM notice and access to annual report

• 34th AGM scheduled Sept 30, 2026 at 04:00 PM via VC/OAVM.
• Notice and FY2025-26 Annual Report accessible via company website and RTA/NSDL/BSE portals.
• Emails sent to registered members; unregistered email holders access notices via provided links.
• E-voting window: cut-off Sept 23, 2026; voting Sept 27–29, 2026.

KYC / demat and compliance updates

• KYC/demat updates required for physical-holding shareholders per SEBI circular.
• KYC forms ISR-1/2/3 and SH-13/14 available on MUFG KYC downloads page.
• Non-registered email holders urged to update contact details to receive communications.
• Dividend/interest/redemption payments to folios with updated signatures electronic-only from Apr 1, 2024.

Financial highlights

• Total income for FY2025-26: ₹4,05,88,068.
• Revenue from operations was nil for FY2025-26.
• Profit before tax: ₹3,91,66,910.
• Profit after tax: ₹3,91,66,910.
• Total expenses: ₹14,21,158.
• Net worth stood at ₹(28,04,365).
• Basic EPS: ₹83.58.
• Weighted average shares: 4,68,636.
• Dividend for FY2025-26 not declared.
• Cash and cash equivalents at year-end: ₹3,17,487.
• Net cash from operating activities: ₹4,00,13,567.
• Proceeds from equity issue: ₹50,00,000; fully utilized.
• Pre-pack insolvency proceedings initiated by NCLT Mumbai Bench.

Capital structure & ownership

• Authorised share capital: ₹11,00,00,000.
• Issued, subscribed and paid-up capital as at 31-03-2026: ₹52,63,157.
• Post-NCLT plan, 50,00,000 new equity shares issued.
• Equity shares subdivided from ₹10 to ₹1.
• Promoter Ravindra Salunkhe holds 50,00,000 shares (95%).
• As at 31-03-2026, shares outstanding: 52,63,157.
• Previous paid-up capital was ₹7,20,02,000.

Dividends & shareholder rights

• Dividend for FY2025-26 not declared.
• No unpaid dividend or IEPF transfers.
• AGM via VC/OAVM on Sep 30, 2026.
• Cut-off date for voting: 23 Sep 2026.
• Notice and AR circulated electronically.

Governance & board changes

• Board reconstituted during year with multiple appointments.
• Ravindra Subhash Salunkhe appointed MD on 10 Mar 2025.
• Bhagyashri Nilesh Devrale ceased as director on 22 Apr 2026.
• Sarita Subhash Salunkhe appointed Additional Non-Executive Director on 14 Aug 2026.
• Independent directors met on 14 Feb 2026.
• Committees: Audit; Nomination & Remuneration; Stakeholder Relationship.

Audit & internal controls

• Statutory Auditor: Laxmikant Kabra & Co.
• Secretarial Auditor: S. V. Kulkarni & Associates.
• Internal Auditor: S S N R & Co.
• CFO not appointed in the year.
• Secretarial audit notes CFO not appointed; website not updated.
• Audit trail feature not present in accounting software; management to enable.
• Pre-pack insolvency order noted; potential impact on operations.
• Internal controls deemed adequate by auditors.

Operations & outlook

• Plant suspended; manufacturing halted due to losses.
• Competition from China contributing to negative performance.
• Management aims to revive operations if market improves.
• No subsidiary or joint venture.
• Risk management policy adopted; internal controls maintained.
• Outlook tied to market conditions and policy stability.

Related party & compliance

• Related party transactions are in ordinary course and arm's length.
• Corporate social responsibility not applicable for FY2025-26.
• Notes to financial statements disclose related party balances.

AGM details

• Date: 30 September 2026; Time: 04:00 PM; Mode: VC/OAVM; Venue: Mumbai.

Resolutions

• Ordinary: adopt audited financial statements for FY 2025-26.
• Ordinary: reappoint Ravindra Subhash Salunkhe as Managing Director (retiring by rotation).
• Ordinary: appoint Sarita Subhash Salunkhe as Non-Executive Non-Independent Director; board authorized to implement.

Voting results

• Voting results not provided in the filing.

Director changes

• Sarita Subhash Salunkhe appointed Additional Director with effect Aug 14, 2026; to be Non-Executive Non-Independent Director.
• She will be liable to retire by rotation.

Financials

• Q1 FY27 unaudited: revenue from operations nil; PBT ₹-10.39 lakh.
• Year ended 31-03-2026: total revenue ₹405.88 lakh; PAT ₹391.67 lakh.
• Q1 FY27 EPS (basic/diluted) ₹-1.97.
• Paid-up equity share capital as of 30-06-2026: ₹52.63 lakh.

Board actions

• Appointment of Mrs. Sarita Subhash Salunkhe as Additional Non-Executive Director, w.e.f. 14-08-2026.

Regulatory filings & AGM

• AGM fixed for 30 Sep 2026 at 04:00 PM via video conference.
• Trading window closed for designated persons from 01 Jul 2026 until 48 hours after results.

Audit & disclosures

• Independent Auditor's Review Report states no material misstatement.
• Emphasis: balances of debtors, creditors, loans and advances subject to confirmation and reconciliation.

Meeting Details

• Date: August 14, 2026; Time: not disclosed; Location: registered office.

Key Agenda Items

• Consider and approve unaudited financial results for quarter ended June 30, 2026 with limited review report.

Other Notes

• Trading window closed from July 1, 2026, until 48 hours after results declaration for designated persons and relatives.